Compare Danaher Corporation (DHR) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Toronto-Dominion Bank — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while Toronto-Dominion Bank trades at $115.1 (market cap $185.79B). The key difference: Toronto-Dominion Bank is the larger of the two by market cap, and Toronto-Dominion Bank pays the higher dividend (2.84%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Toronto-Dominion Bank for 84 Days on average.
| DHR | TD | |
|---|---|---|
Market Cap | $152.87B | $185.79B |
Volume | 5,228,698 | 3,263,867 |
Sector | Health | Financials |
52-Week High | $242.05 | $124.80 |
52-Week Low | $161.91 | $78.32 |
Typical Hold Time | 69 Days | 84 Days |
Enterprise Value | $175.08B | $559.06B |
Dividend Yield | 0.74% | 2.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
TD stock trades at $115.10, up 1.08% with a bearish technical signal despite strong earnings beats in recent quarters. The company maintains solid profitability with 24.88% net income margin and 13.64% ROE, supported by a $10 billion share buyback announcement. Recent news highlights expansion plans including 100 new U.S. branches and a $108 billion commitment to Canadian infrastructure.
The outlook remains positive with analyst consensus favoring Buy ratings (52.94%) and consistent earnings outperformance, though technical indicators suggest near-term pressure. Key risks include volatile cash flows and rising debt-to-asset ratios, while institutional activity shows mixed sentiment with recent insider selling.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
